매상 변화 날짜
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Adma Biologics USD 124.4M 9.9M 2026-06
ALKERMES USD 480.13M 15.88M 2026-09
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
AstraZeneca USD 16.21B 830M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Cipla INR 74.04B 2.85B 2026-09
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 2.6M 3.75M 2026-06
CSL USD 8.33B 4.79B 2025-12
Eli Lilly USD 24.4B 1.43B 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
J&J USD 25.4B 89M 2026-09
Merck USD 18.1B 1.5B 2026-09
Minerva Neurosciences USD 0 0 2024-09
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 16.6B 1.57B 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 14.44B 2.49B 2026-09
Takeda JPY 1.19T 32.9B 2026-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12